Throughout the pandemic our role has evolved 

  • We changed funding criteria to support the health sector and extended thousands of Special Authorities
  • We supported suppliers to ensure all medicines were available for people that needed them
  • We funded treatments for COVID-19 and continue to watch for new treatment
  • We were part of the team that helped broker deals for COVID-19 vaccines